Little Green Pharma And 2 Australian Biotech Stocks To Watch
Australia's economy is under pressure, with rising unemployment and growing talk of recession, which has pushed many investors toward areas that do not move in lockstep with local…
Newsroom · 话题追踪
先读事件,再对照背景与来源。简讯可展开阅读,深度内容可进入全文。
Australia's economy is under pressure, with rising unemployment and growing talk of recession, which has pushed many investors toward areas that do not move in lockstep with local…
Our AI stock portfolio is beating the S&P 500 by 118%. Discover the stocks we're buying and the opportunities we're watching next. Exclusive for Yahoo! Finance readers: 55% off for…
该快讯仅有标题。
查看原文Company Logo Boost ROI with AI analytics, remote monitoring, cloud-based real-world evidence, precision biomarker tracking and wearable injectors that enable at-home biologic deliv…
* Medicus Pharma (MDCX [https://seekingalpha.com/symbol/MDCX]) said on Thursday that it regained compliance with Nasdaq's continued listing requirements. * Nasdaq based its determi…
Medicus Pharma Ltd Nasdaq Confirmation follows CEO-Led $4.25 million in Equity Financings and $10.5 million debt exchange to satisfy the alternative minimum shareholders' equity st…
[Two Medical Students Using Pipette To Dispense Fluid Accurately] Hinterhaus Productions AbbVie (ABBV [https://seekingalpha.com/symbol/ABBV]) has agreed to pay up to $2.54B to coll…
Novartis Pharma AG Ad hoc announcement pursuant to Art. 53 LR Net sales expected to grow at a +5% cc¹ CAGR from 2026 to 2031; core operating income margin¹ on track to return to 40…
LONDON, November 18, 2026--(BUSINESS WIRE)--Ellipses Pharma Limited ("Ellipses") the London-based global oncology drug development company with a pipeline of innovative programmes,…
Novartis Pharma AG Pelabresib 144-week Phase III MANIFEST-2 data show sustained clinical effects in longest follow-up from a combination trial in first-line JAKi-naïve myelofibrosi…